Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/02/2012CN101550188B H5 subtype bird-flue virus H5N1 hemagglutinin monoclonal antibody and nucleic acid sequence and preparation method thereof
05/02/2012CN101365723B Antibodies directed to her-3 and uses thereof
05/01/2012US8168772 Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling
05/01/2012US8168771 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
05/01/2012US8168770 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
05/01/2012US8168759 Compositions monovalent for CD28 binding and methods of use
05/01/2012US8168750 Subunits of the adenovirus fiber protein and uses thereof as vaccines
05/01/2012US8168588 Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions
05/01/2012US8168586 Cancer targets and uses thereof
05/01/2012US8168427 Monoclonal antibodies against claudin-18 for treatment of cancer
05/01/2012US8168421 Microbial vaccine and vaccine vector
05/01/2012US8168418 Expression of HIV polypeptides and production of virus-like particles
05/01/2012US8168415 Axl fusion proteins as Axl tyrosine kinase inhibitors
05/01/2012US8168207 Immunogenic proteins of leptospira
05/01/2012US8168206 Animal protein-free pharmaceutical compositions
05/01/2012US8168205 Streptococcus pneumoniae polypeptides
05/01/2012US8168204 PheP, an amino acid permease of Staphylococcus aureus
05/01/2012US8168203 Shigella protein antigens and methods
05/01/2012US8168202 Hexavalent bovine rotavirus reassortant composition designed for use in developing countries
05/01/2012US8168201 Vaccines
05/01/2012US8168200 Vaccine against african horse sickness virus
05/01/2012US8168199 Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depression
05/01/2012US8168195 Vaccines against Escherichia coli O157 infection
05/01/2012US8168194 Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
05/01/2012US8168193 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/01/2012US8168192 Enterovirus type 71 protein and method for production
05/01/2012US8168191 Cytotoxic T lymphocyte
05/01/2012US8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012US8168188 Antibody and utilization of the same
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168184 Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug
05/01/2012US8168183 Antibodies to granulocyte-macrophage colony-stimulating factor
05/01/2012US8168182 Method for treating erectile dysfunction
05/01/2012US8168181 Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
05/01/2012US8168180 Methods and compositions for modulating angiogenesis
05/01/2012US8168179 Treatment method using anti-PD-L1 antibody
05/01/2012US8168178 Methods and compositions for regulating lymphocyte activity
05/01/2012US8168166 Live genetically attenuated malaria vaccine
05/01/2012US8168164 Targeted conjugates and radiation
05/01/2012CA2583910C Angiopoietin-2 specific binding agents
05/01/2012CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2438425C A novel proteosome-liposaccharide vaccine adjuvant
05/01/2012CA2438080C Gonococcal proteins and nucleic acids
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
05/01/2012CA2322763C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial uc panca antigens
05/01/2012CA2281620C Neurturin receptor
04/2012
04/26/2012WO2012054929A2 Use of human serum albumin to decrease antigenicity of therapeutic proteins
04/26/2012WO2012054920A2 Antigen-specific, tolerance-inducing microparticles and uses thereof
04/26/2012WO2012054879A1 Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia
04/26/2012WO2012054862A2 Agents, compositions, and methods for treating pruritis and related skin conditions
04/26/2012WO2012054807A2 Vaccines comprising bisphosphonate and methods of use thereof
04/26/2012WO2012054755A1 Chlamydia antigens and uses thereof
04/26/2012WO2012054717A2 Detecting and treating solid tumors through selective disruption of tumor vasculature
04/26/2012WO2012054693A1 Uses of yersinia yope peptide, gene, and subparts thereof as a plague vaccine component and assays for yersinia pestis-specific t cells
04/26/2012WO2012054564A2 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
04/26/2012WO2012054502A1 Identification of antibodies specific for lyssaviruses and methods of their use
04/26/2012WO2012054438A1 Anti-pcsk9
04/26/2012WO2012054294A1 Her2 dna vaccine as adjunct treatment for cancers in companion animals
04/26/2012WO2012054084A2 Antibodies
04/26/2012WO2012054077A2 Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
04/26/2012WO2012053928A1 Immunologically active substance, process for preparing same, bioprobe, pharmaceutical composition, diagnostics and treatment methods
04/26/2012WO2012053828A2 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
04/26/2012WO2012053206A1 Wdhd1 peptides and vaccines including the same
04/26/2012WO2012053200A1 C18orf54 peptides and vaccines including the same
04/26/2012WO2012052748A1 Method for immunising a subject against mycobacterium tuberculosis or mycobacterium bovis
04/26/2012WO2012052394A1 Method of storing a vaccine containing an aluminum adjuvant
04/26/2012WO2012052384A1 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
04/26/2012WO2012052230A1 Erbb3 binding antibody
04/26/2012WO2012052205A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
04/26/2012WO2012051707A1 Methods for the prevention and/or treatment of memory impairment
04/26/2012WO2012023051A3 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
04/26/2012WO2012021249A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
04/26/2012WO2012021247A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
04/26/2012WO2012021165A9 Methods and compositions for treating disorders associated with hyperactive immune system
04/26/2012WO2012014078A3 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
04/26/2012WO2012014073A3 Vaccines against pregnancy-associated malaria
04/26/2012WO2012010978A3 A method of treating alzheimer's disease
04/26/2012WO2012010973A3 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
04/26/2012WO2012010970A3 A method of treating attention deficit hyperactivity disorder
04/26/2012WO2012009289A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
04/26/2012WO2012007839A3 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
04/26/2012WO2012006550A3 Methods and compositions for treatment of lipogenic virus related conditions
04/26/2012WO2012006490A3 Dual variable domain immunoglobulins and uses thereof
04/26/2012WO2012005550A3 Pharmaceutical composition for treating gallbladder carcinoma, and method for inhibiting growth and metastasis of gallbladder carcinoma and treating gallbladder carcinoma, using same
04/26/2012WO2011160026A3 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
04/26/2012WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures
04/26/2012WO2011149909A3 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
04/26/2012WO2011044561A9 Attenuated influenza viruses and vaccines
04/26/2012WO2011024071A8 Adjuvant comprising aluminium, oligonucleotide and polycation
04/26/2012WO2010119343A8 Compositions for immunising against staphylococcus aureus
04/26/2012WO2000053787A9 Prrsv vaccines
04/26/2012US20120100210 Composition for the administration of polymeric drugs
04/26/2012US20120100186 Nanoparticulate-based contraceptive/anti-hiv composition and methods
04/26/2012US20120100182 Continuous Cell Programming Devices
04/26/2012US20120100181 Attenuation of Encephalitogenic Alphavirus and Uses Thereof
04/26/2012US20120100180 Methods for proliferation of antigen-specific t cells
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 1823